Safinamide for Multiple System Atrophy (MSA)

Clinical trial NCT03753763 · COMPLETED

Trial details

NCT number: NCT03753763
Sponsor: Zambon SpA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple System Atrophy

Start date: 2019-10-29
Primary completion: 2021-01-05
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.